Drug Approval | April 21, 2022
Dr. Reddy's launch Posaconazole delayed-release tablets in the US
The tablets are available in 100 mg strength in bottle count sizes of 60
The tablets are available in 100 mg strength in bottle count sizes of 60
Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
Researchers have developed a plasma-based disinfectant generated with the help of cold atmospheric pressure plasma (CAP) which could act as a green decontaminant for Covid-19
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
The company also plans to expand the facility
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
The peptide-based vaccine induces a t cell-dependent response
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Both companies have been selected for stand-by production by German government
Subscribe To Our Newsletter & Stay Updated
